FOSB and neoplasm: Endeavors towards the development of the Activator protein-1 (AP-1) transcription factor family as novel molecular biomarkers and therapeutic targets for human cancers have been ongoing due to their extensive involvement in all aspects of tumor biology and prominent clinical relevance as previously reported [8, 42].